Antibiotic use in relation to the risk of breast cancer

By C. Velicer, S. Heckbert, Johanna W. Lampe, John D. Potter, C. Robertson, Stephen H. Taplin. Journal of the American Medical Association (JAMA), 2004

3,266 citations recorded by the source corpus.

Subfields: Oncology, Pollution

View Paper: https://www.semanticscholar.org/paper/18879d241fcfb47373fb78b87a63d26beced2898

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Guido Kroemer
2. L. Zitvogel
3. E. Golden
4. Matthias Mann
5. S. Formenti
6. Xi Wang
7. R. Khalil
8. M. Shibuya

Citations in the corpus

• Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. (2016, background): “In humans, epidemiological studies suggested a dose-dependent association between antibiotic use and risk of BC (Blaser, 2011; Velicer et al., 2004).”
• Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. (2004, background): “The identification of markers for the early recognition of bacterial infections could guide treatments, reduce misuse of antibiotics, and possibly improve long-term outcomes [5].”
• The emergence of Lyme disease. (2004, background): “Furthermore, prolonged use of antibiotics was recently associated with an increased risk of breast cancer (90).”
• Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. (2011, background): “demonstrated an intimate relationship between the serum levels of sFlt-1 and the degree of preeclampsia.(49) This strongly suggests that abnormal suppression of VEGF-A by sFlt-1 causes hypertension and proteinuria in the patients.”
• A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate (2008, background): “An anti-angiogenic state has been implicated as a mechanism of disease in PE [16,19,20,27].”
• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. (2018, background): “Placental ischemia is also associated with increased release of bioactive factors (Levine et al., 2004; Gilbert et al., 2007; Gilbert et al., 2009; Reslan and Khalil, 2010; Palei et al., 2013b), which could target various vascular mediators and MMPs in ECM, endothelial cells and VSM leading to…”
• Revisiting biomarker discovery by plasma proteomics (2017, background): “Examples are the 60-year-old De Ritis ratio of ASAT/ALAT to differentiate between causes of liver disease (De-Ritis et al, 1957) or the more recent sFlt-1/PlGF ratio for diagnosis of preeclampsia (Levine et al, 2004).”
• Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. (2008, background): “Strontium chloride (Sigma) and sodium ranelate (Servier, France) were added to the culture medium at a molar ratio of 100:1, respectively, in order to reflect the ratio found in the blood of postmenopausal osteoporotic patients treated with strontium ranelate [25].”
• The effects of oxidative stress on female reproduction: a review (2012, background): “tor for VEGF (sFlt-1) [203], which has anti-angiogenic properties [150,204].”